Skip to content
Medical Health Aged Care

Celebrating International Nurses Day 2025

The Australian Nursing and Midwifery Federation (ANMF) 2 mins read

On this International Nurses Day (IND), the ANMF is recognising and celebrating the dedication, skill, and compassion of nursing professionals, who deliver quality care when it is needed most across the community. This year’s IND theme Our Nurses. Our Future. Caring for nurses strengthens economies, emphasises the need to support the health and well-being of nurses.

 

ANMF Federal Secretary Annie Butler said a healthy Australian nursing workforce is critical in building a stronger Australian health system and providing better patient care across the community.

 

“Happy International Nurses Day to all of our members,” Ms Butler said.

 

“On this very special day, we stop to recognise the amazing dedication and commitment our nurses have for the people they care for in their communities. And we acknowledge that nurses are the foundation of Australia’s system of quality, universal healthcare. 

 

“IND gives us the opportunity to think about why we must place greater emphasis on caring for nurses, looking after their mental health and their workplace environment and safety to allow them to work to their full potential and in turn, lead to better health outcomes.”

 

The ANMF has implemented programs which better support nurses, including the establishment of the Nurse Midwife Health Program Australia (NMHPA), a free and confidential counselling support service, providing support to improve the health and well-being of nurses, midwives and students. The Albanese Government listened and acted on the ANMF’s advocacy efforts, with a $25.2 million grant over five years to roll-out the service across the country.

 

“The NMHPA is one everyday example of how we’ve collaborated with the Government to better support nurses with increased funding and programs which are helping retain our current nursing professionals and recruit more new nurses into the workforce,” Ms Butler explained.

 

“We’re pleased that the Albanese Government has already committed to the ANMF’s key priorities, such as paid prac placements for nursing students; the removal of outdated barriers preventing nurse practitioners working to their full scope of practice and a 20% reduction in university loan debt; which all focus on supporting nurses now and into the future.”

More from this category

  • Government Federal, Medical Health Aged Care
  • 25/06/2025
  • 00:05
ACSQHC

Spirometry in decline: a vital test for COPD left behind

25 June 2025 Australians living with chronic obstructive pulmonary disease (COPD) are being exposed to greater health risks as the use of a critical diagnostic test has fallen dramatically, according to a new national report released today by the Australian Commission on Safety and Quality in Health Care. The Atlas Focus Report: COPD found a 31% drop in spirometry testing rates between 2015-16 and 2022-23, despite the test being the gold standard for confirming a diagnosis of COPD. Without spirometry, patients are in danger of misdiagnosis and being prescribed medications that put them at unnecessary risk. COPD is a progressive,…

  • Contains:
  • Medical Health Aged Care
  • 24/06/2025
  • 23:26
Zepp Health

Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance

Amazfit Smart Wearables Require No Additional Subscription MILPITAS, Calif.–BUSINESS WIRE– Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), a…

  • Contains:
  • Medical Health Aged Care
  • 24/06/2025
  • 21:10
Fortrea Holdings Inc

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studiesDURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current Good Manufacturing Practice (cGMP) and Good Laboratory Practice (GLP), to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction (DDI) studies, to certify impurities are below the Acceptable Intake (AI) Limit set by U.S. Food and Drug Administration (FDA)…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.